- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced and Metastatic Breast Cancer in China
Total 7185 results
-
Tianjin Medical University Cancer Institute and...CompletedPyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast CancerHER2-positive Advanced Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...UnknownHormone Receptor Positive Advanced Breast CancerChina
-
CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruiting
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.CompletedMetastatic Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...UnknownMetastatic Breast CancerChina
-
Fudan UniversityUnknownMetastatic Breast CancerChina
-
Fudan UniversityCompletedMetastatic Breast CancerChina
-
Liaoning Tumor Hospital & InstituteCompletedHER2-positive Metastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Tianjin Medical University Cancer Institute and...UnknownAnthracycline-pretreated Metastatic Breast CancerChina
-
Zhejiang Cancer HospitalProswell Medical CorporationRecruitingMetastatic Breast CancerChina
-
Hunan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Breast CancerChina
-
Henan Cancer HospitalActive, not recruitingMetastatic Breast CancerChina
-
Hunan Cancer HospitalCompletedMetastatic Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownMetastatic Breast CancerChina
-
Zhejiang Cancer HospitalUnknownMetastatic Breast CancerChina
-
Sun Yat-sen UniversityCompletedBreast Cancer MetastaticChina
-
AstraZenecaActive, not recruitingLocally Advanced (Inoperable) or Metastatic Breast CancerUnited States, Italy, Spain, Belgium, Hungary, Poland, Canada, France, Germany, Korea, Republic of, Japan, Peru, Russian Federation, United Kingdom, China, Taiwan, Israel, Australia, Argentina
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Triple-Negative Breast CancerChina
-
First Affiliated Hospital of Shantou University...Guangdong ProCapZoom Biosciences Co., Ltd.Not yet recruitingAdvanced Triple Negative Breast CancerChina
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina
-
Fudan UniversityCompletedAdvanced Triple-Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Genor Biopharma Co., Ltd.UnknownHER-2-positive Advanced Breast CancerChina
-
Zhejiang Cancer HospitalRecruitingHER2-positive Advanced Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityGuangzhou Anjie Biomedical Technology Co., Ltd.CompletedAdvanced Breast Cancer | Breast Neoplasm Malignant FemaleChina
-
wang shusenRecruitingAdvanced HER2 Negative Breast Carcinoma HRD+Breast CancerChina
-
Zunyi Medical CollegeRecruitingHER-2 Positive Advanced Breast CancerChina
-
Tianjin Medical University Cancer Institute and...RecruitingAdvanced HER2 Negative Breast Carcinoma | HRD+Breast CancerChina
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedHER2-positive Metastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHER2 Positive Metastatic Breast CancerChina
-
Shandong Suncadia Medicine Co., Ltd.RecruitingUnresectable or Metastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingChemotherapy Effect | Locally Advanced Breast CancerChina
-
Fudan UniversityRecruiting
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Breast Cancer | Metastatic Triple Negative Breast CancerJapan, Belgium, France, Netherlands
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySun Yat-sen University; First People's Hospital of FoshanCompletedMetastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedER+ / HER2- Advanced Breast CancerChina
-
RenJi HospitalBeijing Viroad Biotechnology Co., Ltd.CompletedLocally Advanced Breast Cancer | Circulating Tumor CellChina
-
Shanghai Pudong HospitalDuke UniversityRecruitingMetastatic Cancer | Advanced CancerChina
-
Yongsheng WangJiangsu HengRui Medicine Co., Ltd.RecruitingLocally Advanced Breast Cancer | Hormone Receptor Positive,HER2-negative Breast CancerChina
-
Fujian Cancer HospitalNot yet recruitingAdvanced Triple Negative Breast CancerChina
-
Xuanzhu Biopharmaceutical Co., Ltd.Active, not recruitingAdvanced Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTargeted Therapy | HR+/HER2- Advanced Breast CancerChina